123 related articles for article (PubMed ID: 2907943)
1. [Long-term effect of xamoterol "Corwin", beta 1 partial agonist, on hemodynamics and treadmill exercise in patients with previous myocardial infarction].
Shimizu M; Tsuyusaki T; Kawaguchi T; Kitazumi H; Yoshizawa Y; Kuramochi K; Kawano M; Kodama T; Kawano T; Ogata N
Kokyu To Junkan; 1988 Dec; 36(12):1339-46. PubMed ID: 2907943
[No Abstract] [Full Text] [Related]
2. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
de Feyter PJ; Serruys PW; Suryapranata H
Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
[TBL] [Abstract][Full Text] [Related]
3. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA
Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945
[No Abstract] [Full Text] [Related]
4. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
5. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Watanabe K; Hirokawa Y; Shibata A
J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
[TBL] [Abstract][Full Text] [Related]
6. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
7. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
[No Abstract] [Full Text] [Related]
9. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF
Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076
[TBL] [Abstract][Full Text] [Related]
10. Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
Shabetai R
Cardiology; 1990; 77(5):357-66. PubMed ID: 1981492
[TBL] [Abstract][Full Text] [Related]
11. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
[No Abstract] [Full Text] [Related]
12. Hemodynamic effects of ICI 118.587 (Corwin) in patients with mild cardiac failure after myocardial infarction.
Svensson G; Rehnqvist N; Sjögren A; Erhardt L
J Cardiovasc Pharmacol; 1985; 7(1):97-101. PubMed ID: 2580158
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Sørensen EV; Faergeman O; Day MA; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
[TBL] [Abstract][Full Text] [Related]
14. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
[TBL] [Abstract][Full Text] [Related]
15. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
Molajo AO; Bennett DH
Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834
[TBL] [Abstract][Full Text] [Related]
16. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
Vigholt-Sørensen E; Faergeman O; Snow HM
Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
[TBL] [Abstract][Full Text] [Related]
17. The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease.
Molajo AO; Bennett DH; Marlow HF; Snow HM; Bastain W
Br J Clin Pharmacol; 1987 Sep; 24(3):373-9. PubMed ID: 2889460
[TBL] [Abstract][Full Text] [Related]
18. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
[TBL] [Abstract][Full Text] [Related]
19. Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
Sashida H; Sakai K; Hino T; Abiko Y
Pharmacology; 1986; 33(6):301-10. PubMed ID: 2882527
[TBL] [Abstract][Full Text] [Related]
20. Acute hemodynamic and metabolic effects of ICI 118,587 (Corwin), a selective partial beta 1 agonist, in patients with dilated cardiomyopathy.
Bhatia SJ; Swedberg K; Chatterjee K
Am Heart J; 1986 Apr; 111(4):692-6. PubMed ID: 2869673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
